Clinical trial NCT05737342 - References

Metabolic Syndrome — Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

Citation(s)

•   Chen CL, Pan TM
  Effects of red mold dioscorea with pioglitazone, a potentially functional food, in the treatment of diabetes. J Food Drug Anal. 2015 Dec;23(4):719-728. doi: 10.1016/j.jfda.2015.04.013. Epub 2015 Jul 21.
•   Hsu LC, Hsu YW, Hong CC, Pan TM
  Safety and mutagenicity evaluation of red mold dioscorea fermented from Monascus purpureus NTU 568. Food Chem Toxicol. 2014 May;67:161-8. doi: 10.1016/j.fct.2014.02.033. Epub 2014 Feb 28.
•   Lee BH, Hsu WH, Huang T, Chang YY, Hsu YW, Pan TM
  Monascin improves diabetes and dyslipidemia by regulating PPARgamma and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice. Food Funct. 2013 Jun;4(6):950-9. doi: 10.1039/c3fo60062a. Epub 20
•   Liu SF, Wang YR, Shen YC, Chen CL, Huang CN, Pan TM, Wang CK
  A randomized, double-blind clinical study of the effects of Ankascin 568 plus on blood lipid regulation. J Food Drug Anal. 2018 Jan;26(1):393-400. doi: 10.1016/j.jfda.2017.04.006. Epub 2017 Jun
•   Shi YC, Liao JW, Pan TM
  Antihypertriglyceridemia and anti-inflammatory activities of monascus-fermented dioscorea in streptozotocin-induced diabetic rats. Exp Diabetes Res. 2011;2011:710635. doi: 10.1155/2011/710635. Epub 2011 May 11.
•   Shi YC, Pan TM
  Anti-diabetic effects of Monascus purpureus NTU 568 fermented products on streptozotocin-induced diabetic rats. J Agric Food Chem. 2010 Jul 14;58(13):7634-40. doi: 10.1021/jf101194f.
•   Shi YC, Pan TM
  Antioxidant and pancreas-protective effect of red mold fermented products on streptozotocin-induced diabetic rats. J Sci Food Agric. 2010 Nov;90(14):2519-25. doi: 10.1002/jsfa.4115.
•   Slim R, Ben Salem C, Zamy M, Biour M
  Pioglitazone-induced acute rhabdomyolysis. Diabetes Care. 2009 Jul;32(7):e84. doi: 10.2337/dc09-0593. No abstract available. Erratum In: Diabetes Care. 2010 Jun;33(6):1406. Zami, Michele [corrected to Zamy, Michele].
•   Wang YR, Liu SF, Shen YC, Chen CL, Huang CN, Pan TM, Wang CK
  A randomized, double-blind clinical study to determine the effect of ANKASCIN 568 plus on blood glucose regulation. J Food Drug Anal. 2017 Apr;25(2):409-416. doi: 10.1016/j.jfda.2016.06.011. Ep

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research

Details for clinical trial NCT05737342